Search by Drug Name or NDC

NDC 70954-0228-10 Methsuximide 300 mg/1 Details

Methsuximide 300 mg/1

Methsuximide is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is METHSUXIMIDE.

MedlinePlus Drug Summary

Methsuximide is used to control absence seizures (petit mal; a type of seizure in which there is a very short loss of awareness during which the person may stare straight ahead or blink his eyes and does not respond to others) that cannot be treated with other medications. Methsuximide is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.

Related Packages: 70954-0228-10
Last Updated: 05/12/2024
MedLinePlus Full Drug Details: Methsuximide

Product Information

NDC	70954-0228
Product ID	70954-228_5138e347-665b-4dd6-b9f8-12f4a807ed4e
Associated GPIs
GCN Sequence Number	004553
GCN Sequence Number Description	methsuximide CAPSULE 300 MG ORAL
HIC3	H4B
HIC3 Description	ANTICONVULSANTS
GCN	17411
HICL Sequence Number	001890
HICL Sequence Number Description	METHSUXIMIDE
Brand/Generic	Generic
Proprietary Name	Methsuximide
Proprietary Name Suffix	n/a
Non-Proprietary Name	Methsuximide
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	300
Active Ingredient Units	mg/1
Substance Name	METHSUXIMIDE
Labeler Name	ANI Pharmaceuticals, Inc.
Pharmaceutical Class	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA217213
Listing Certified Through	2024-12-31

Package

NDC 70954-0228-10 (70954022810)

Pricing Information	N/A
NDC Package Code	70954-228-10
Billing NDC	70954022810
Package	100 CAPSULE in 1 BOTTLE (70954-228-10)
Marketing Start Date	2023-05-01
NDC Exclude Flag	N